$12M Boost for AI Driven Pharmaceutical Startup Persist AI

0 33 Less than a minute

Persist AI Powers Up with $12M Investment

Sacramento based startup Persist AI has successfully closed a $12 million Series A funding round, led by Spero Ventures with notable participation from Eli Lilly & Company, SignalFire, and Y Combinator. By combining cutting edge robotics with artificial intelligence, Persist AI is revolutionizing how pharmaceutical companies develop drug formulations.

Persist AI’s Cloud Lab Attracts $12M in New Funding

Their Cloud Lab platform allows researchers to remotely design and test complex drug recipes, cutting down both the time and resources traditionally required.

The new investment will help Persist AI expand its robotic capabilities and support a wider range of pharmaceutical products from pills and capsules to injectable medicines.

This technology promises to make drug development faster, more efficient, and accessible to teams worldwide.